
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 22790
[patent_doc_number] => 07799904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Gilvocarcin gene cluster, recombinant production and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/866089
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 9
[patent_no_of_words] => 13444
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866089 | Gilvocarcin gene cluster, recombinant production and use thereof | Jun 13, 2004 | Issued |
Array
(
[id] => 7103496
[patent_doc_number] => 20050106222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Method to increase protein production in culture'
[patent_app_type] => utility
[patent_app_number] => 10/864348
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12892
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106222.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864348
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864348 | Method to increase protein production in culture | Jun 9, 2004 | Abandoned |
Array
(
[id] => 5921304
[patent_doc_number] => 20060239988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Neuronal regeneration and compound administration methods'
[patent_app_type] => utility
[patent_app_number] => 10/559871
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 33647
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20060239988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559871 | Neuronal regeneration and compound administration methods | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7056432
[patent_doc_number] => 20050277607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Compositions and methods for regulating peptidyltransferase activity and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/864079
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13251
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277607.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864079 | Compositions and methods for regulating peptidyltransferase activity and uses thereof | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7428640
[patent_doc_number] => 20040209364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'AAV vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection'
[patent_app_type] => new
[patent_app_number] => 10/485937
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5097
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485937 | AAV vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection | Jun 8, 2004 | Abandoned |
Array
(
[id] => 6971680
[patent_doc_number] => 20050037390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Methods and compositions for modulating erythropoietin expression'
[patent_app_type] => utility
[patent_app_number] => 10/862013
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14850
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862013 | Methods and compositions for modulating erythropoietin expression | Jun 3, 2004 | Abandoned |
Array
(
[id] => 5252745
[patent_doc_number] => 20070134201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Archaeon expression system'
[patent_app_type] => utility
[patent_app_number] => 10/559583
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8193
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559583 | Archaeon expression system | Jun 1, 2004 | Issued |
Array
(
[id] => 6996257
[patent_doc_number] => 20050136035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site'
[patent_app_type] => utility
[patent_app_number] => 10/857498
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22270
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857498 | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site | May 31, 2004 | Abandoned |
Array
(
[id] => 7426758
[patent_doc_number] => 20040229833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Therapeutic use of cis-element decays in vivo'
[patent_app_type] => new
[patent_app_number] => 10/850994
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4274
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850994 | Therapeutic use of cis-element decays in vivo | May 19, 2004 | Abandoned |
Array
(
[id] => 5034161
[patent_doc_number] => 20070098700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Synthetic mammalian retotransposon gene'
[patent_app_type] => utility
[patent_app_number] => 10/558804
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 9173
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098700.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558804
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558804 | Synthetic mammalian retrotransposon gene | May 17, 2004 | Issued |
Array
(
[id] => 7427499
[patent_doc_number] => 20040209247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'E1-revertant-free adenoviral composition'
[patent_app_type] => new
[patent_app_number] => 10/844133
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11663
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844133 | E1-revertant-free adenoviral composition | May 11, 2004 | Abandoned |
Array
(
[id] => 7089055
[patent_doc_number] => 20050009168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods and apparatus for Adeno associated virus purification'
[patent_app_type] => utility
[patent_app_number] => 10/843718
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3916
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009168.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843718 | Methods and apparatus for Adeno associated virus purification | May 10, 2004 | Abandoned |
Array
(
[id] => 7103833
[patent_doc_number] => 20050106559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Viral vector'
[patent_app_type] => utility
[patent_app_number] => 10/841603
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 48661
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10841603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841603 | Viral vector | May 6, 2004 | Issued |
Array
(
[id] => 7060593
[patent_doc_number] => 20050002953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'SARS-coronavirus virus-like particles and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/839729
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15334
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839729 | SARS-coronavirus virus-like particles and methods of use | May 3, 2004 | Abandoned |
Array
(
[id] => 7348679
[patent_doc_number] => 20040248301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences'
[patent_app_type] => new
[patent_app_number] => 10/837029
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 32635
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10837029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/837029 | Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences | Apr 29, 2004 | Issued |
Array
(
[id] => 7252697
[patent_doc_number] => 20050142617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'High bone mass gene of 11q13.3'
[patent_app_type] => utility
[patent_app_number] => 10/834377
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 39668
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834377 | High bone mass gene of 11q13.3 | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7061121
[patent_doc_number] => 20050003482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site'
[patent_app_type] => utility
[patent_app_number] => 10/831302
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19426
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003482.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831302 | Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site | Apr 25, 2004 | Issued |
Array
(
[id] => 121216
[patent_doc_number] => 07709224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site'
[patent_app_type] => utility
[patent_app_number] => 10/831304
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 22811
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831304 | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site | Apr 25, 2004 | Issued |
Array
(
[id] => 5759591
[patent_doc_number] => 20060210536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Methods and compositions for inhibiting stat signaling pathways'
[patent_app_type] => utility
[patent_app_number] => 10/553160
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32034
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553160 | Methods and compositions for inhibiting stat signaling pathways | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7010832
[patent_doc_number] => 20050064548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Yeast ectopically expressing abnormally processed proteins and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/826157
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14519
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064548.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826157 | Yeast ectopically expressing abnormally processed proteins and uses therefor | Apr 15, 2004 | Abandoned |